EUVIMEDEUVIMED entdecken
Leserbrief

Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data

Leo Boneschansker, Ashwin N Ananthakrishnan, Massachusetts General Hospital Crohn’s And Colitis Center Collaborators

Clinical Gastroenterology and Hepatology · 2023-08 · 21 (9) · 2427-2429.e1

DOI: 10.1016/j.cgh.2023.03.040 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-08. Verfasst von Leo Boneschansker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Crohn's and Colitis Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Janus Kinase Inhibitors. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeJanus Kinase InhibitorsHumansPiperidinesPyrimidinesHeterocyclic Compounds, 3-Ring

Substanzen

PiperidinesPyrimidinesJanus Kinase InhibitorstofacitinibupadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Massachusetts General Hospital Crohn's and Colitis Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.
  • Massachusetts General Hospital Crohn's and Colitis Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: aananthakrishnan@mgh.harvard.edu.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Boneschansker, L., Ananthakrishnan, A. N., & Massachusetts General Hospital Crohn’s And Colitis Center Collaborators (2023). Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data. Clinical Gastroenterology and Hepatology, 21(9), 2427-2429.e1. https://doi.org/10.1016/j.cgh.2023.03.040

Vancouver

Boneschansker L, Ananthakrishnan AN, Massachusetts General Hospital Crohn’s And Colitis Center Collaborators. Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data. Clinical Gastroenterology and Hepatology. 2023;21(9):2427-2429.e1. doi:10.1016/j.cgh.2023.03.040

BibTeX
@article{Boneschansker2023,
  author = {Boneschansker, Leo and Ananthakrishnan, Ashwin N and Massachusetts General Hospital Crohn’s And Colitis Center Collaborators, Massachusetts General Hospital Crohn’s And Colitis Center Collaborators},
  title = {Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2427--2429.e1},
  doi = {10.1016/j.cgh.2023.03.040}
}
Kostenlos starten →